BridgeMD
New treatment option for Post Operative Analgesia
Official title Supplementary Nerve Blocks Added to the Adductor Canal Block for Postoperative Pain Management in Primary Total Knee Arthroplasty: A Randomized Controlled Comparison of Sciatic, BiFeS, and IPACK Techniques
ClinicalTrials.gov ID: NCT07242170
What this study is testing
- What it's testing
- Postoperative pain following total knee arthroplasty (TKA) is a significant clinical problem that delays early mobilization, reduces patient satisfaction, and increases analgesic requirements. The adductor canal block (ACB), which aims to provide analgesia while preserving motor function, is widely used in postoperative pain management after TKA.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Patients classified as American Society of Anesthesiologists (ASA) physical status I-III
- Patients undergoing primary total knee arthroplasty
- Patients undergoing unilateral total knee arthroplasty
- Patients between 18 and 75 years of age
You likely can't join if
- Patients classified as American Society of Anesthesiologists (ASA) physical status IV or higher
- Patients undergoing revision total knee arthroplasty
- Patients undergoing bilateral total knee arthroplasty
- Patients with neuromuscular disease
- Patients who decline to participate in the study
- Patients with cognitive dysfunction
See the full eligibility criteria
- Patients classified as American Society of Anesthesiologists (ASA) physical status I-III
- Patients undergoing primary total knee arthroplasty
- Patients undergoing unilateral total knee arthroplasty
- Patients between 18 and 75 years of age
- Patients classified as American Society of Anesthesiologists (ASA) physical status IV or higher
- Patients undergoing revision total knee arthroplasty
- Patients undergoing bilateral total knee arthroplasty
- Patients with neuromuscular disease
- Patients who decline to participate in the study
- Patients with cognitive dysfunction
- Patients with known drug allergies
- Patients with a history of local anesthetic systemic toxicity
- Patients with neurological dysfunction
- Patients with bleeding diathesis
- Pregnant patients
The study team makes the final eligibility decision.
Where it's taking place
- Erzincan, Merkez, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Erzincan, Merkez, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.